New programming created to help recognize patients requiring ventilator support: Govt Kumar Jeetendra | June 19, 2021 The government on Saturday said that a new software — Covid Severity Score — has been developed to identify patients who require ventilator support as well as detect emergency and intensive care unit needs early. The software consists of an algorithm that measures a set of parameters, and then identifies patients likely to require ventilator …
Delta variant establishes more than 6% of tested COVID-19 cases with virus variant in NYC: Health division Kumar Jeetendra | June 19, 2021 The Delta variant, first detected in India, constituted over 6 per cent of COVID-19 cases tested for virus variants in New York City, according to official data from the city’s health department. The New York City Health Department said in its recent update that out of the 105 NYC COVID-19 cases tested for variant viruses …
Brazil probes Health Ministry arrangement to purchase Covaxin vaccine Kumar Jeetendra | June 23, 2021 Brazil’s federal prosecutor’s office is investigating possible irregularities in a Health Ministry contract to purchase 20 million doses of the Covaxin vaccine manufactured by Indian laboratory Bharat Biotech. The agreement signed in February commits the ministry to pay USD 320 million – at a cost of USD 15 per vaccine dose – to Precisa Medicamentos, …
Pfizer, Moderna vaccines cut COVID-19 danger by 91%: Study Kumar Jeetendra | July 8, 2021 People who receive COVID-19 vaccines by Pfizer and Moderna are up to 91 per cent less likely to develop the disease, according to a US study which also suggests that the preventives reduce the severity of symptoms and duration in those who still get an infection. The research, published in the New England Journal of …
Bharat Biotech’s partner Ocugen looks for endorsement for Covaxin in Canada Kumar Jeetendra | July 16, 2021 Ocugen Inc., Bharat Biotech’s partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the jab, the US company said in a regulatory filing. The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, …
Johnson and Johnson raises figures, estimates $2.5 billion in COVID-19 vaccine deals Kumar Jeetendra | July 21, 2021 Johnson & Johnson on Wednesday raised its overall revenue estimate for the year and forecast $2.5 billion in sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns. Although Johnson & Johnson’s shot was approved in the United …
Coronavirus Delta variant to rule within months : WHO Kumar Jeetendra | July 21, 2021 The highly contagious Delta variant of Covid-19 is expected to become the dominant strain of the virus over the coming months, the World Health Organization said Wednesday. Delta, which was first detected in India, has now been recorded in 124 territories — 13 more than last week — and already accounts for more than three-quarters …
China says ”shocked” by WHO plan for COVID source: Study Kumar Jeetendra | July 22, 2021 A senior Chinese health official said Thursday he was shocked by the World Health Organisation’s plan for the second phase of a COVID-19 origins study. National Health Commission Vice Minister Zeng Yixin dismissed the lab leak theory as a rumor running counter to common sense. The head of the WHO acknowledged last week that it …
New COVID variant ‘likely’ this year: Top French master Kumar Jeetendra | July 23, 2021 The French government’s top advisor on COVID-19 warned Friday that a new variant of the disease would “probably” emerge in the winter months this year. The country is currently battling an unprecedented spike in new cases caused by the more infectious Delta variant, which was first recorded in India. “We will probably have another variant …
Should vaccinated personals mask up with COVID-19 cases rising? Kumar Jeetendra | July 23, 2021 It depends on your situation, but masking in public can provide another layer of protection and help prevent the virus from spreading to others who aren’t protected. An easing of safety precautions and the large number of people who remain unvaccinated in many regions are contributing to the spread of cases around the world. The …
AstraZeneca to look for US approval of Coronavirus immunization in second half Kumar Jeetendra | July 29, 2021 AstraZeneca said on Thursday that it intends to seek US authorization for its COVID-19 vaccine in the second half of this year, offering a new timetable for the much-delayed application. The Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its sub-licensees delivered more than 700 million …
Hard-won increases in risk as Delta variant spreads: WHO Kumar Jeetendra | August 1, 2021 The world is at risk of losing hard-won gains in fighting COVID-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on Friday. The U.S. Centers for Disease Control and Prevention (CDC) has described the Delta variant of the coronavirus as being as transmissible as chickenpox and …
